OGC
RNAM

One68 Global Capital’s Avidity Biosciences RNAM Stock Holding History

One68 Global Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$216K – 61
2025
Q4 		$216K Buy
+3,000
New +$194K 2.55% 21

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

One68 Global Capital's RNAM Position: Q1 2026 in Review

One68 Global Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,000 shares — an estimated $216K sold.

One68 Global Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • One68 Global Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • One68 Global Capital sold 3,000 Avidity Biosciences shares in Q1 2026, an estimated $216K.
  • One68 Global Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • One68 Global Capital's Avidity Biosciences position peaked at $216K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on One68 Global Capital's 13F filing for Q1 2026, filed 15 May 2026.